Kattula is a second-year resident psychiatrist at University of Missouri Kansas City, in Kansas City, Missouri. Kattula completed a medical degree from Andhra Medical College in India. After practicing medicine in India, she moved to USA with her family. She worked as a clinical observer at various hospitals in Iowa including University of Iowa, Trinity Health Care and Mercy Care, and also at St. Mary’s hospital in Connecticut. Along with familiarizing the US clinical system, she pursued an interest in research at University of Iowa in the area of prostate cancer research in the lab of Dr. David Lubaroff. Later, due to her interest in psychiatry, she joined Dr. John Wemmie’s lab in the Department of Psychiatry at the University of Iowa where her focus was the utilization of proton exchange MRI to study metabolic abnormalities in the brain. Kattula’s research works were culminated in poster presentations and publications.

During Kattula’s residency at UMKC, she has been receiving rigorous training in managing patients of ages ranging from 18 to 60 with wide variety of psychological disorders of varying severity. During her first year, she presented a poster on the topic of “managing psychiatric/behavioral problems in a patient with chromosome 18 deletion syndrome” in American Psychiatry Association Meeting-2018, New York City, NY along with coauthoring 2 other posters. Recently, her abstract regarding Cognitive Enhancement Therapy in real-world schizophrenia population got accepted for American Psychiatry Association meeting that will be held in May, 2019.

Presentation(s): 

Substance-Induced Neurocognitive Disorder